Clinical Guest Contributors
-
Merck Maintains Human Touch In AI-Assisted Patient Recruitment And Education
10/2/2025
SVP and Head of Global Clinical Trial Operations Jen Sheller shares how Merck’s “Zero Gravity” program and human-enabled AI are streamlining clinical research while honoring the human insights essential for trial success.
-
FDA Pharma Advertising Crackdown Reshapes Clinical Research, Too
10/1/2025
Empactul Ventures' Denise N. Bronner, Ph.D., explores how the FDA's crackdown on pharmaceutical advertising might affect clinical research patient recruitment and engagement.
-
Proximity To Patients Helps Unicycive Reduce Pill Burden
10/1/2025
Unicycive CEO Shalabh Gupta, MD, shares how the company integrates patient feedback into the design of its trials, thus reducing pill burden.
-
Age Diversity In Clinical Trials: Considerations For Improving Older Adult Representation
9/30/2025
Without prioritizing age diversity in recruitment and enrollment, research findings aren’t fully generalizable to this key demographic, limiting the applicability of trials. Let's look at what drug sponsors can do.
-
Pediatric Clinical Trials Must Approach Research With Today's And Tomorrow's Kids In Mind
9/30/2025
Phoenix Children’s SVP of Research Stewart Goldman, MD, describes their patient-centric approach, offering insights into patient selection and education, as well as trial design.
-
GCP Oversight Simplified: A Quick Guide
9/29/2025
Discover practical, real-world strategies for sponsors to operationalize GCP oversight in a way that is collaborative, measurable, and scalable.
-
Powering Standards With Code: The Role Of Open Source In CDISC 360i
9/26/2025
Discover how to implement CDISC standards in automated research data pipelines that are fast, scalable, and reliable.
-
Site-Level Change Model And Successful Strategies For Medicare Compliance In Clinical Trials
9/26/2025
Discover best practices for achieving and maintaining Medicare billing compliance for clinical trials.
-
What The FDA Says About Investigator Responsibilities In DCTs
9/25/2025
Learn exactly what the FDA says about the use of healthcare providers (HCPs), telemedicine, licensing, and practice standard requirements when executing a DCT.
-
How Skipping The CRO Helped RenovoRx Get Closer To Patients
9/24/2025
RenovoRx Chief Clinical Officer Leesa Gentry explains why they decided to forgo a CRO partner.